Client Result
Orrick Advises Kain Capital on Investment in MY DR NOW
September.01.2022
The investment marks the first time MY DR NOW has received external capital.
September.01.2022
The investment marks the first time MY DR NOW has received external capital.
June.06.2022
May.24.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.
May.24.2022
May.13.2022
April.27.2022
April.13.2022
March.30.2022
March.24.2022
February.28.2022
February.28.2022
January.10.2022